These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

472 related items for PubMed ID: 18243932

  • 1. Preventing herpes zoster through vaccination.
    Gelb LD.
    Ophthalmology; 2008 Feb; 115(2 Suppl):S35-8. PubMed ID: 18243932
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
    Pellissier JM, Brisson M, Levin MJ.
    Vaccine; 2007 Nov 28; 25(49):8326-37. PubMed ID: 17980938
    [Abstract] [Full Text] [Related]

  • 3. Vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia.
    Betts RF.
    J Am Acad Dermatol; 2007 Dec 28; 57(6 Suppl):S143-7. PubMed ID: 18021866
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity.
    Liesegang TJ.
    Ophthalmology; 2008 Feb 28; 115(2 Suppl):S3-12. PubMed ID: 18243930
    [Abstract] [Full Text] [Related]

  • 6. Vaccination: a new option to reduce the burden of herpes zoster.
    Mick G.
    Expert Rev Vaccines; 2010 Mar 28; 9(3 Suppl):31-5. PubMed ID: 20192716
    [Abstract] [Full Text] [Related]

  • 7. Shingles vaccine.
    Willison CB, Morrison LK, Mendoza N, Tyring SK.
    Expert Opin Biol Ther; 2010 Apr 28; 10(4):631-8. PubMed ID: 20113211
    [Abstract] [Full Text] [Related]

  • 8. Cost-effectiveness of vaccination against herpes zoster and postherpetic neuralgia: a critical review.
    Kawai K, Preaud E, Baron-Papillon F, Largeron N, Acosta CJ.
    Vaccine; 2014 Mar 26; 32(15):1645-53. PubMed ID: 24534737
    [Abstract] [Full Text] [Related]

  • 9. [Herpes zoster and postherpetic neuralgia - prevention by vaccination?].
    Wutzler P.
    Dtsch Med Wochenschr; 2009 Apr 26; 134 Suppl 2():S90-4. PubMed ID: 19353479
    [Abstract] [Full Text] [Related]

  • 10. Prevention strategies: herpes zoster, post-herpetic neuralgia and immunogenicity.
    Levin MJ, Schmader K.
    Herpes; 2007 Sep 26; 14 Suppl 2():45-7. PubMed ID: 17939896
    [Abstract] [Full Text] [Related]

  • 11. Herpes zoster vaccine awareness among people ≥ 50 years of age and its implications on immunization.
    Javed S, Javed F, Mays RM, Tyring SK.
    Dermatol Online J; 2012 Aug 15; 18(8):2. PubMed ID: 22948052
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Vaccination to prevent herpes zoster in older adults.
    Gnann JW.
    J Pain; 2008 Jan 15; 9(1 Suppl 1):S31-6. PubMed ID: 18166463
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Vaccination for preventing postherpetic neuralgia.
    Chen N, Li Q, Zhang Y, Zhou M, Zhou D, He L.
    Cochrane Database Syst Rev; 2011 Mar 16; (3):CD007795. PubMed ID: 21412911
    [Abstract] [Full Text] [Related]

  • 18. Health economic evaluation of vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia in Germany.
    Ultsch B, Weidemann F, Reinhold T, Siedler A, Krause G, Wichmann O.
    BMC Health Serv Res; 2013 Sep 26; 13():359. PubMed ID: 24070414
    [Abstract] [Full Text] [Related]

  • 19. A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia.
    Holcomb K, Weinberg JM.
    J Drugs Dermatol; 2006 Oct 26; 5(9):863-6. PubMed ID: 17039651
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.